Symbol Lookup

Sunday March 29, 2015 9:39 AM ET. Data delayed 15 minutes.
14.30
0.26 (1.85%)
Bid/Lots
14.30/140
Ask/Lots
14.34/7
Open/Prev Close
13.89/14.04
Day Range
13.80-14.48
52-Week Range
4.40-15.24
Vol/Avg Daily Vol
254.4K/414.0K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
CytoSorbents to Report Fiscal 2014 Operating and Financial Results
7:00AM ET on Tuesday Mar 24, 2015 by PR Newswire

CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb(R) extracorporeal cytokine adsorber to treat critically-ill and cardiac surgery patients in multiple countries worldwide, will report...

CytoSorbents Plans Robust Agenda at ISICEM 2015
8:30AM ET on Friday Mar 13, 2015 by PR Newswire

CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy commercializing its CytoSorb(R) extracorporeal cytokine adsorber to purify blood and control severe inflammation, today announced its agenda for the 35th Internati...

Cytosorbents Shares Up Pre-Market on Launch of Website for Flagship Product, CytoSorb Therapy
9:07AM ET on Wednesday Mar 11, 2015 by Midnight Trader
09:07 AM EDT, 03/11/2015 (MT Newswires) -- Cytosorbents (CTSO) shares rose in Wednesday's pre-market session after the critical-care immunotherapy company launched the product website for its flagship product, CytoSorb Therapy, which is designed ...
CytoSorbents Launches New International CytoSorb(R) Therapy Product Website
8:30AM ET on Wednesday Mar 11, 2015 by PR Newswire

CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb(R) extracorporeal cytokine adsorber to treat critically-ill and cardiac surgery patients in multiple countries worldwide, announced t...

Company Information

CytoSorbents Corporation is a development stage critical care focused immunotherapy company using blood purification to modulate inflammation to preventing or treating multiple organ failure in life-threatening illnesses. The technology is based upon biocompatible, highly porous polymer sorbent beads that are capable of extracting unwanted substances, such as drugs, dangerous chemicals, toxins, cytokines, free hemoglobin, and antibodies, from blood and other bodily fluids. In addition to CytoSorb, the Company is developing other products utilizing its adsorbent polymer technology that have not received regulatory approval including HemoDefend, ContrastSorb, DrugSorb, BetaSorb and others.

CONTACT INFORMATION

Headquarters7 Deerpark Dr Ste K
MONMOUTH JUNCTION, NJ, United States 08852-1921
Phone732-329-8885
Fax732-329-8650

EXECUTIVE OFFICERS

Chairman of the BoardAl Kraus
President, Chief Executive Officer, DirectorPhillip Chan
Chief Financial OfficerKathleen Bloch
Chief Operating OfficerVincent Capponi
Chief Medical OfficerRobert Bartlett

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$350.5MBeta0.45
Revenue (TTM)$4.1MEPS$-0.82
Shares Out.24.5MBook Value$0.10
Dividend Yield0.00%P/E--
Annual Dividend Rate$0.00Price/Sales (TTM)84.9
Ex-Div Date1/1/01P/Cash Flow (TTM)--
Pay Date1/1/01Operating Margin-126.64%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample